Xoma
BOX 2344, Göteborg, Västra Götaland County, 403 15, Sweden
Overview
Xoma is focused on building and commercialising proprietary technology that enables the efficient cultivation of algae. The company positions its solution as a sustainable platform with multiple downstream applications, although specific verticals were not detailed in the article. Management plans to use fresh capital to accelerate ongoing projects and broaden commercial expansion initiatives. According to CEO Mourad Lahdo, the new funds also strengthen day-to-day working capital, giving the firm greater operational flexibility. Xoma raised approximately SEK 12.2 million through a directed share issue, issuing 40 million new B-shares at SEK 0.305 each, a 16 % discount to the recent volume-weighted average price. The transaction results in roughly 38 % dilution for existing shareholders. Founders Dennis Pedersen and Eddie Jalmestam participated alongside 33 new investors, signalling continued insider confidence in the business.
- Total raised
- $1M
- Funding rounds
- 1
- Latest round
- Series B
- Latest activity
- Oct 2025
Industries
- Alternative Protein
- Biopharma
- Biotechnology
- Sustainability
Recent funding
Series B
Oct 2025
$1M
Team
No current team members are available.